Public support for healthcare-mediated disclosure of hereditary cancer risk information: Results from a population-based survey in SwedenAndréas Andersson, Anna Rosén, Barbro Numan Hellquist et al.|Hereditary Cancer in Clinical Practice|2020Cited by 44
Direct letters to relatives at risk of hereditary cancer—study protocol for a multi-center randomized controlled trial of healthcare-assisted versus family-mediated risk disclosure at Swedish cancer genetics clinics (DIRECT-study)Carolina Hawranek, Anna Rosén, Hans Ehrencrona et al.|Trials|2023Cited by 6
Direct letters to relatives at risk of hereditary cancer—a randomised trial on healthcare-assisted versus family-mediated risk disclosureHans Ehrencrona, Anna Rosén, Anna Öfverholm et al.|European Journal of Human Genetics|2025Cited by 6
Direct letters to relatives at risk of hereditary cancer – study protocol for a multi-centre randomised controlled trial of healthcare-assisted versus family-mediated risk disclosure at Swedish cancer genetics clinics (DIRECT-study)Carolina Hawranek, Anna Rosén, Anna Öfverholm et al.|Research Square|2023Cited by 2